Jemperli Injection is a breakthrough immunotherapy medicine containing Dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody that enhances the body’s immune response against cancer cells. It is indicated for the treatment of recurrent or advanced endometrial cancer and other MSI-H (microsatellite instability-high) or dMMR (mismatch repair deficient) solid tumors that hav... https://www.drugsgeneral.com/jemperli-injection/